hotspot -WSS

hotspot

author：hotspot 2025-09-03 11:46:53 - browse：547

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Overprescribed: High cost isn't America's only drug problem

WSS

People with mental disorders often marry others with same

Update the Apgar Score to remove skin color

Study: Black kids more likely to die after surgery than white kids

Bird flu reported in person exposed to presumably infected cattle

Multiple sclerosis has subtypes with different best treatments: study

Update the Apgar Score to remove skin color

knowledge

hotspot

entertainment

Psychedelics group wrestles with new pharma identity

Mass General Brigham physicians react to latest merger step

Duchenne breakthrough therapy leaves behind pioneering families

FDA endorses new sterilization method for medical devices

Anesthesiologist group: stop taking Ozempic before surgery

Dog Aging Project founders on what lies ahead after losing funding

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Affirmative action in medical school literally saved lives

Trial using CRISPR to edit HIV out of cells disappoints

focus

Bird flu in dairy cattle: New measures to control spread to humans

Four alarming medical procedures we’re glad history forgot

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Young boy dies in trial for Pfizer Duchenne gene therapy

Overprescribed: High cost isn't America's only drug problem

Hundreds died while taking an arthritis drug, but nobody alerted patients

Wikipedia

knowledge

knowledge

hotspot